Preventim and treatment of uremia accompanied by vascular calcification by hemoperfusion combined with hemodialysis-filtration
AN Shuqiang1,YANG Qian1,CUI Ling1,SHI Changsheng1,and JIA Xiaojuan2
1.Hebei Provincial Corps Hosptial of Chinese People’s Armed Police Forces,Shijiazhuang 050081,China;2. Anal Fistula Specialist Hospital of Zhao County,Shijiazhuang 051530, China
Abstract：Objective To investigate the effect of hemoperfusion(HP) combined with hemodialysis-filtration(HDF) on prevention and control of vascular calcification in uremic patients. Methods From this hospital we recruited 60 patients with chronic renal failure and uremia, randomly divided into 2 groups. Group A underwent hemoperfusion(HP) combined with hemodialysis-filtration(HDF); groups B received traditional hemodialysis(HD). Comparative analysis of the correlation among different indexes before and after first time treatment and finished at 24 weeks, such as parathyroid hormone(PTH), fibroblast growth factor23(FGF23), cartilage olgomeric matrix protein(COMP), bone morphogenetic protein 2(BMP-2),calcium(Ca2+),phosphorus(P3+). Vascular calcification was evaluated by chest, pelvis and hands X-ray examination before first time treatment and after 24 weeks of treatment. Analysis of the correlation among different indexes and multivariate logistic regression analysis of risk factors of vascular calcification were carried out. Results Comparing group A and group B before treatment, there were no statistically significant differences in PTH, FGF23, BALP, COMP, BMP-2, P3+ (P>0.05). In group A ,compared between before and after the first time of treatment, and between the first time of treatment and the last time of treatment there was statistically significant difference (P<0.05). Multivariate logistic regression analysis showed that PTH, FGF23, BALP , COMP, BMP-2 ,P3+ and phosphorus are risk factors of vascular calcification . Conclusions Hemoperfusion(HP)combined with hemodialysis-filtration(HDF) can effectively prevent uremia accompanied by vascular calcification.
Iijima K,Hashimoto H,Hashimoto M,et al.Aortic arch calcification detectable on chest X-ray is a strong independent predictor of cardiovascular events beyond traditional risk factors[J].Atherosclerosis,2010,210(1):137-144.
[4]
Iijima K,Hashimoto H,Hashimoto M,et al.Aortic arch calcification detectable on chest X-ray is a strong independent predictor of cardiovascular events beyond traditional risk factors[J].Atherosclerosis,2010,210(1):137-144.
[5]
Kidney Disease Improving Global Outcomes(KDIGO)CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis,evalution,prevention,and treatment of chronic kidney disease-mineral and bone disorder(CKD-MBD)[J].Kidney Int,2009,76(Suppl 113):S1-13.
[5]
Kidney Disease Improving Global Outcomes(KDIGO)CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis,evalution,prevention,and treatment of chronic kidney disease-mineral and bone disorder(CKD-MBD)[J].Kidney Int,2009,76(Suppl 113):S1-13.
[6]
Jono S,Shioi A,Ikari Y,et al. Vascular calcification in the chronic kidney disease[J].J Bone Miner Metab,2006,24(2):176-181.
[6]
Jono S,Shioi A,Ikari Y,et al. Vascular calcification in the chronic kidney disease[J].J Bone Miner Metab,2006,24(2):176-181.
[7]
Mirza M A,Hansen T,Johansson L,et al.Relationship between circulating FGF23 and toal body atherosclerosis in the community[J].Nephrol Dial Transplant,2009,24(10):3125-3131.
[7]
Mirza M A,Hansen T,Johansson L,et al.Relationship between circulating FGF23 and toal body atherosclerosis in the community[J].Nephrol Dial Transplant,2009,24(10):3125-3131.
[8]
Wang L,Zheng J,Bai X, et al.ADAMIS-7 mediates vascular smooth muscle cell migration and neointima formation in balloon-injured rat arteries[J].Circ Res,2009,104(5):688-698.
[8]
Wang L,Zheng J,Bai X, et al.ADAMIS-7 mediates vascular smooth muscle cell migration and neointima formation in balloon-injured rat arteries[J].Circ Res,2009,104(5):688-698.
[9]
Belovici M I,Pandele G I,Revista M C, et al.Arterial media calcification in patients with type 2 diabetes mellitus[J].Rev Med Chir Soc Med Nat Iasi,2008,112(1):21-34.
[9]
Belovici M I,Pandele G I,Revista M C, et al.Arterial media calcification in patients with type 2 diabetes mellitus[J].Rev Med Chir Soc Med Nat Iasi,2008,112(1):21-34.
[10]
Hruska K A.The pathogenesis of vascular calcification in the chronic kidney disease mineral and bone disorder:The links between bone and the vasculature[J].Semin Nephrol,2009,29(2):156-165.
[10]
Hruska K A.The pathogenesis of vascular calcification in the chronic kidney disease mineral and bone disorder:The links between bone and the vasculature[J].Semin Nephrol,2009,29(2):156-165.
[11]
Suki W N,Zabaneh R,Cangiano J L,et al.Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients. [J]. Kidney Int,2007,72(8):1130-1137.
[11]
Suki W N,Zabaneh R,Cangiano J L,et al.Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients. [J]. Kidney Int,2007,72(8):1130-1137.
Marietjie H, Nazeema E, Jeanne M K, et al. Relationship between serum protein and mortality in adults on long-term hemodialysis: Exhaustive review and meta-analysis[J]. Nutrition, 2010, 26(1):10-32.
[14]
Marietjie H, Nazeema E, Jeanne M K, et al. Relationship between serum protein and mortality in adults on long-term hemodialysis: Exhaustive review and meta-analysis[J]. Nutrition, 2010, 26(1):10-32.
2013, Vol. 24 
